May 6, 2013:

Lytix Biopharma attends CIMT (Cancer Immunotherapy) annual meeting 2013

Apr 8, 2013:

Lytix Biopharma attended the American Association for Cancer Research (AACR) annual meeting

Apr 3, 2013:

Lytix Biopharma'’s infection drug candidate has the potential to treat and prevent skin infections

Feb 22, 2013:

Lytix Biopharma enrolls first patient in LTX-109 Phase II PoC infection study